TY - JOUR A1 - Allig, Sebastian A1 - Mayer, Margot A1 - Thielemann, Christiane T1 - Workflow for bioprinting of cell-laden bioink JF - Lekar a technika – Clinician and Technology N2 - Applying technologies of additive manufacturing to the field of tissue engineering created a pioneering new approach to model complex cell systems artificially. Regarding its huge potential, bioprinting is still in its infancies and many questions are still unanswered. To address this issue, an extrusion-based bioprinting (EBB) process was used to deposit human embryonic kidney (HEK) cells in a defined pattern. It was shown that the bioprinted construct featured a high degree in viability reaching up to 77% 10 days after printing (DAP). This work displays a proof of principle for a controlled cell formation which shall later be applied to in vitro drug screening tests using various types of cells. KW - Extrusion-based bioprinting KW - bioink KW - tissue engineering KW - in vitro cell systems KW - Biomaterial KW - Biomedizinische Technik Y1 - 2018 VL - 48 IS - 2 SP - 46 EP - 51 ER -